https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Dental-MS.jpg

Dental Bone Graft Substitutes Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | 10 MedSuites | Includes: Allografts, Xenografts, Synthetic Bone Grafts, Dental Barrier Membranes & Dental Growth Factor Devices

  • Year: 2021
  • Scope: 10 Years
  • Region: Argentina, Australia, Brazil, China, Europe, India, Japan, Mexico, South Korea, United States
  • Published Date: 03/26/2021
  • Type: MedSuite

This Global Report Series represents iData’s entire collection of country-level reports in the Global Dental Bone Graft Substitute market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s publication year:

US Dental Bone Graft Substitutes Market

In 2021, the US dental bone graft substitutes (DBGS) market size is expected to reach $390 million, with the Allograft market showing the fastest growth. In spite of COVID19, the US market size is expected to increase over the forecast period to exceed $540 million in 2027. Over 40% of the dental bone graft substitutes market share in the US was dominated by three main competitors – Geistlich, Zimmer Biomet, and ACE Surgical.

US Dental Bone Graft Substitute Market Size Growth, 2017-2027

Dental bone graft substitutes market growth in the US will be driven by continued technological developments that allow companies to introduce new products with innovations to increase the ease of use and patient comfort. This research takes a closer look at new product launches, specifically in the innovation-rich segments like the barrier membrane market, to understand the impact on the Average Selling Prices (ASPs) and the overall market value.

Europe Dental Bone Graft Substitutes Market

In 2021, the EU dental bone graft substitutes market size is projected to reach $272 million, which is a recovery of over 30% when compared to 2020. In spite of COVID19, the EU market size is expected to increase over the forecast period to exceed $372 million in 2027. Currently, over 40% of the dental bone graft substitutes market share in Europe is dominated by two main competitors – Geistlich and Botiss Biomaterials.

Europe Dental Bone Graft Substitute Market Size Growth, 2017-2027

The growing number of GPs placing implants is driving the European market for dental bone graft substitutes forward by increasing the volume of dental implant procedures. The growing number of GPs placing implants increases the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw prior to the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate dental biomaterials.

Asia Pacific Dental Bone Graft Substitutes Market

In 2021, the Asia Pacific dental bone graft substitutes market size is projected to reach $295 million, which the Chinese market showing the most promising growth. In spite of COVID19, the Asia Pacific market size is expected to increase over the forecast period to exceed $667 million in 2027.

An ongoing trend within the South Korean and Indian markets for dental bone graft substitutes is the increasing market share of dental barrier membranes. In these markets, dental barrier membranes have yet to achieve similar market penetration as other developed dental markets, such as the United States. Given the high rate of dental implants placed in South Korea and India, the dental barrier membrane market is poised to experience significant growth over the forecast period.

In the Japan and Australian markets, a major limiter preventing market growth in the dental bone graft substitute and other biomaterials market is the strict regulatory environment. This largely limits competition and the products available to the these market. As a result of limited products, patients may instead opt to travel to other regions of the world to undergo a DBGS procedure.

Latin America Dental Bone Graft Substitutes Market

In 2021, the Latin America dental bone graft substitutes market size is projected to reach $72 million, which the Brazilian market showing the most promising growth. In spite of COVID19, the LAtin American market size is expected to increase over the forecast period to exceed $161 million in 2027.

The Mexican dental bone graft substitute market growth will be driven by continued technological developments that allow companies to introduce new products with innovations to increase the ease of use and patient comfort. New product launches have the effect of expanding a company’s product mix and capture more of the market while maintaining a steady or growing ASP in innovation-rich segments like the barrier membrane market, leading to a higher market value overall.

In the Argentinian market, dental professionals have made attempts to reduce the risk of contamination and spread of disease in bone grafting procedures. As tissue banks have gained complete control of the allograft market, they have been able to set certain rules and standards regarding these products. In hopes of reducing the spread of disease through implantation treatments, tissue banks have implemented intense laws and regulations in the use of allograft materials that prevent retailers from selling them on the market.

Dental Bone Graft Substitutes Market Share Insights

Geistlich is a clear leader in the dental bone graft substitutes market, particularly in Europe, where they command more than one-third of the market share themselves. The U.S. market sees stronger competition from Zimmer Biomet, ACE Surgical, and BioHorizons to compete as leaders in this space. Geistlich’s emerging market share in the overall market is a direct result of their dominance strictly within the xenograft market. The Bio-Oss® bovine xenograft product line in the xenograft realm of DBGS is recognized as the gold standard within the xenograft market. In fact, the product is the clear leader of the xenograft market.

Combining the dental divisions of each company, Zimmer Dental and BIOMET 3i merged in June of 2015, creating an entity that rivals that of Geistlich in the United States. The company continues to maintain a strong presence in the overall DBGS market by providing products in the mineralized allograft, DBM allograft, xenograft, and synthetic sub-segments of the market. In the European market, Zimmer Biomet still trails behind Botiss Biomaterials.

Botiss continues to experience significant growth, largely owing to its distribution deal established with Straumann, a leading dental implant manufacturer. The company is headquartered in Berlin, Germany and has R&D and production sites in Germany, Austria and the United Kingdom. Unlike Geistlich, the leading competitor in the market, Botiss maintains a much more varied product portfolio in the dental biomaterial market. Though the company is most successful in the xenograft segment, Botiss also produces and distributes allograft and synthetic DBGS materials.

Dental Bone Graft Substitutes Market Segmentation

While this Global Series contains all global dental bone graft substitutes market data, each of the market segments is also available as a stand-alone report, MedCore. This allows you to get access to only the dental bone graft substitutes market research that you need.

  • Dental Bone Grafting Procedure Numbers | US | 2021-2027 | MedPro – Using a number of databases, internal and external, we’re able to provide the volume of dental bone grafting procedures being performed in the US, including dental implant and periodontal procedures performed using bone graft substitutes.
  • Dental Bone Graft Substitute Market | US, EU15*, Asia Pacific*, Latin America* | 2021-2027 | MedCore – The market analysis is further broken down into segments, such as Mineralized Allografts, Demineralized Bone Matrix (DBM) Allografts, Xenografts, and Synthetic Bone Grafts.
  • Dental Barrier Membrane Market | US, EU15*, Asia Pacific*, Latin America* | 2021-2027 | MedCore – The chapter contains the market analysis which is categorized by:
    • Device Type: Resorbable and Non-Resorbable Dental Barrier Membranes;
    • Material Type: Xenograft, Synthetic, and Allograft.
  • Dental Growth Factor Market | US, EU15*, Latin America | 2021-2027 | MedCore – The market analysis is also further segmented by:
    • Device Type: Emdogain®, GEM 21S®, Infuse™, and Osteocel® devices.

*Limited Coverage Available. Please consult the respective reports for more information.

Research Scope Summary

Report Attribute Details
Regions United States, EU15, Asia Pacific (South Korea, China, India, Japan, Australia), Latin America (Brazil, Mexico, Argentina)
Base Year 2020 – United States, Asia Pacific, Latin America
2019 – Europe
Forecast 2021-2027 – United States, Asia Pacific, Latin America
2019-2025 – Europe
Historical Data 2017-2020 – United States, Asia Pacific, Latin America
2015-2018 – Europe
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

Top Dental Bone Graft Substitute Companies Analyzed

  • AB Dental
  • ACE Surgical
  • Advanced BioTech Products Ltd.
  • Allgens
  • Alpha-Bio Tec
  • Amann Girrbach
  • Anthogyr
  • Arthrex
  • Augma Biomaterials
  • Australia Biotechnologies
  • B&W
  • Baumer
  • BEGO
  • Beijing YHJ Science and Trade Co.
  • Benco
  • BenQ Corporation
  • Bicon
  • BIOBank
  • BioHorizons
  • Biomatlante
  • BioMimetic
  • BiosLight S.A. de C.V.
  • Biotek
  • Bioxen
  • Botiss Biomaterials
  • BTI
  • Cells + Tissuebank Austria
  • Ceramisys
  • Citagenix
  • Collagen Matrix
  • CoorsTek
  • Cortex Dental
  • CowellMedi
  • Criteria
  • Curasan
  • Danaher Corporation
  • Datum Dental
  • Degradable Solutions
  • Dental Wings
  • Dentegris
  • Dentium USA
  • Dentsply Sirona
  • Dyna Dental
  • Equinox
  • Euroteknika
  • Exactech
  • FGM
  • G. Surgiwear
  • GC Corporation
  • Geistlich
  • Genoss
  • Hans Biomed
  • Henry Schein
  • HOYA Technosurgical
  • IFGL Bio Ceramics Limited
  • Impladent LTD
  • Implant Direct
  • InBiomed
  • Inion
  • Intralock
  • JHS
  • Kasios
  • KaVo Kerr
  • Keramat
  • Keystone Dental
  • KOKEN
  • KYOCERA
  • Laboratorio Celina
  • LifeNet Health
  • Lutipold Pharmaceuticals
  • Lynch Biologics
  • Matcom
  • Medica-Integral
  • Medtronic
  • MegaGen
  • MIS Implants
  • MTF
  • Neobiotech
  • Neodent
  • Neoss
  • NIBEC
  • Nobel Biocare
  • Noraker
  • NovaBone
  • Odontit
  • Olympus Terumo Biomaterials
  • Oscotec
  • Osseocon
  • Ossix Dental
  • Osstem Implant
  • OST Development
  • Osteogenics
  • Osteohealth
  • OT Medical
  • Patterson
  • Pharmatrix
  • Regentix
  • Resorba
  • Rocky Mountain Tissue Bank
  • S.I.N.
  • Salvin
  • Shanghai Rebone Biomaterials
  • Shanxi OsteoRad
  • Sheng Chi Biotechnology
  • Silvestre Labs
  • Sistema INP
  • Snoasis Medical
  • Straumann
  • Sunmax Biotechnology
  • Sunstar
  • Tecnoss
  • Tianjin Sannie
  • Tirden
  • Tissue Banks
  • TreeOss
  • UNC
  • Unicare BioMedical
  • W. L. Gore
  • Zimmer Biomet

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

For the complete Table of Contents from any of the Country-Level reports in this Global Series, please navigate to the respective reports:

Dental Bone Graft Substitutes Market Analysis | United States | 2021-2027 | MedSuite
Dental Bone Graft Substitutes Market Analysis | Europe | 2019-2025 | MedSuite
Dental Bone Graft Substitutes Market Analysis | China | 2021-2027 | MedSuite
Dental Bone Graft Substitutes Market Analysis | South Korea | 2021-2027 | MedSuite
Dental Bone Graft Substitutes Market Analysis | India | 2021-2027 | MedSuite
Dental Bone Graft Substitutes Market Analysis | Japan | 2021-2027 | MedSuite
Dental Bone Graft Substitutes Market Analysis | Australia | 2021-2027 | MedSuite
Dental Bone Graft Substitutes Market Analysis | Brazil | 2021-2027 | MedSuite
Dental Bone Graft Substitutes Market Analysis | Argentina | 2021-2027 | MedSuite
Dental Bone Graft Substitutes Market Analysis | Mexico | 2021-2027 | MedSuite

US DENTAL BONE GRAFT SUBSTITUTE MARKET

TABLE OF CONTENTS I
LIST OF FIGURES VII
LIST OF CHARTS X
EXECUTIVE SUMMARY 1
U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
MARKETS INCLUDED 7
KEY REPORT UPDATES 8
VERSION HISTORY 8
RESEARCH METHODOLOGY 9
Step 1: Project Initiation & Team Selection 9
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design 14
Step 4: Performing Primary Research 15
Step 5: Research Analysis: Establishing Baseline Estimates 17
Step 6: Market Forecast and Analysis 18
Step 7: Identify Strategic Opportunities 20
Step 8: Final Review and Market Release 21
Step 9: Customer Feedback and Market Monitoring 22

IMPACT OF COVID-19 ON THE U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET

2.1 INTRODUCTION 23
2.2 MULTI-SCENARIO ANALYSIS 25
2.2.1.1 Best Case Scenario 25
2.2.1.2 Base Case Scenario 26
2.2.1.3 Worst Case Scenario 27

DISEASE OVERVIEW

3.1 BASIC ANATOMY 29
3.1.1 Dental Anatomy: Oral Cavity and Intraoral Landmarks 29
3.2 DISEASE PATHOLOGY AND DISORDERS 30
3.2.1 General Diagnostics 30
3.2.2 Indication for Dental Implant 30
3.2.3 Periodontal Disease 31
3.2.4 Dental Implant Procedures 32
3.2.5 Guided Bone Regeneration 33
3.3 PATIENT DEMOGRAPHICS 34
3.3.1 General Dental Statistics 34
3.3.2 Tooth Loss Statistics 35

PRODUCT ASSESSMENT

4.1 INTRODUCTION 37
4.2 PRODUCT PORTFOLIOS 37
4.2.1 Dental Bone Graft Substitutes 37
4.2.1.1 Allografts 38
4.2.1.1.1 Mineralized Allografts 38
4.2.1.1.2 Demineralized Bone Matrix 38
4.2.1.2 Autografts 39
4.2.1.3 Synthetics 40
4.2.1.4 Xenografts 41
4.2.2 Dental Growth Factors 44
4.2.3 Dental Barrier Membrane 45
4.3 REGULATORY ISSUES AND RECALLS 47
4.3.1 Geistlich 47
4.4 CLINICAL TRIALS 48
4.4.1 Dental Grafts 48

U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET OVERVIEW

5.1 INTRODUCTION 51
5.1.1 Applications of Dental Bone Graft Substitutes 51
5.1.1.1 Dental Implant Procedures 52
5.1.1.2 Periodontal Procedures 52
5.1.2 Types of Dental Bone Graft Substitutes 52
5.1.2.1 Autografts 52
5.1.2.2 Allografts 53
5.1.2.3 Demineralized Bone Matrix Allografts 54
5.1.2.4 Xenografts 54
5.1.2.5 Synthetics 54
5.1.3 Dental Growth Factor Products 55
5.1.4 Dental Membranes 55
5.1.5 Market Penetration and End Users 56
5.2 MARKET OVERVIEW 57
5.3 TREND ANALYSIS BY SEGMENT 63
5.4 DRIVERS AND LIMITERS 66
5.4.1 Market Drivers 66
5.4.2 Market Limiters 68
5.5 COMPETITIVE MARKET SHARE ANALYSIS 71
5.6 MERGERS AND ACQUISITIONS 79
5.7 COMPANY PROFILES 81
5.7.1 ACE Surgical 81
5.7.2 BioHorizons 82
5.7.3 Dentsply Sirona 83
5.7.4 Geistlich 84
5.7.5 LifeNet Health 85
5.7.6 Medtronic 86
5.7.7 Osteogenics Biomedical 87
5.7.8 Zimmer Biomet 88
5.8 SWOT ANALYSIS 89
5.8.1 ACE Surgical 90
5.8.2 BioHorizons 91
5.8.4 Dentsply Sirona 92
5.8.5 Geistlich 93
5.8.6 LifeNet Health 94
5.8.7 Medtronic 95
5.8.8 Osteogenics Biomedical 96
5.8.9 Zimmer Biomet 97

PROCEDURE NUMBERS

6.1 INTRODUCTION 98
6.2 DENTAL BONE GRAFTING PROCEDURES 99

DENTAL BONE GRAFT SUBSTITUTE MARKET

7.1 INTRODUCTION 105
7.1.1 Autografts 105
7.1.2 Allografts 106
7.1.2.1 Mineralized Allografts 106
7.1.2.2 Demineralized Bone Matrix 107
7.1.3 Xenografts 107
7.1.4 Synthetics 108
7.2 MARKET OVERVIEW 109
7.3 MARKET ANALYSIS AND FORECAST 114
7.3.1 Total Dental Bone Graft Substitute Market 114
7.3.2 Total Allograft Market 117
7.3.2.1 Mineralized Allograft Market 122
7.3.2.2 Demineralized Bone Matrix Allograft Market 125
7.3.3 Xenograft Market 127
7.3.4 Synthetic Bone Graft Market 130
7.4 UNIT ANALYSIS 132
7.4.1 Bone Graft Substitute Unit Sales by Type 132
7.5 DRIVERS AND LIMITERS 135
7.5.1 Market Drivers 135
7.5.2 Market Limiters 137
7.6 COMPETITIVE MARKET SHARE ANALYSIS 140

DENTAL GROWTH FACTOR MARKET

8.1 INTRODUCTION 146
8.2 MARKET OVERVIEW 147
8.3 MARKET ANALYSIS AND FORECAST 151
8.3.1 Emdogain® Market 151
8.3.2 GEM 21S® Market 154
8.3.3 Infuse® Market 157
8.3.4 Osteocel® Market 160
8.4 DRIVERS AND LIMITERS 163
8.4.1 Market Drivers 163
8.4.2 Market Limiters 164
8.5 COMPETITIVE MARKET SHARE ANALYSIS 167

DENTAL BARRIER MEMBRANE MARKET

9.1 INTRODUCTION 171
9.2 MARKET OVERVIEW 174
9.3 MARKET ANALYSIS AND FORECAST 179
9.3.1 Total Dental Barrier Membrane Market 179
9.3.2 Resorbable Dental Barrier Membrane Market 182
9.3.3 Non-Resorbable Dental Barrier Membrane Market 184
9.3.3.1 Non-Reinforced Non-Resorbable Dental Barrier Membrane Market 189
9.3.3.2 Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market 191
9.4 UNIT ANALYSIS 193
9.4.1 Dental Barrier Membrane Unit Sales by Size 193
9.4.1.1 Resorbable Dental Barrier Membranes by Size 193
9.4.1.2 Non-Resorbable Dental Barrier Membranes by Size 195
9.4.2 Dental Barrier Membrane Unit Sales by Material 197
9.5 DRIVERS AND LIMITERS 201
9.5.1 Market Drivers 201
9.5.2 Market Limiters 202
9.6 COMPETITIVE MARKET SHARE ANALYSIS 204

ABBREVIATIONS

Top Dental Bone Graft Substitute Companies Analyzed

  • AB Dental
  • ACE Surgical
  • Advanced BioTech Products Ltd.
  • Allgens
  • Alpha-Bio Tec
  • Amann Girrbach
  • Anthogyr
  • Arthrex
  • Augma Biomaterials
  • Australia Biotechnologies
  • B&W
  • Baumer
  • BEGO
  • Beijing YHJ Science and Trade Co.
  • Benco
  • BenQ Corporation
  • Bicon
  • BIOBank
  • BioHorizons
  • Biomatlante
  • BioMimetic
  • BiosLight S.A. de C.V.
  • Biotek
  • Bioxen
  • Botiss Biomaterials
  • BTI
  • Cells + Tissuebank Austria
  • Ceramisys
  • Citagenix
  • Collagen Matrix
  • CoorsTek
  • Cortex Dental
  • CowellMedi
  • Criteria
  • Curasan
  • Danaher Corporation
  • Datum Dental
  • Degradable Solutions
  • Dental Wings
  • Dentegris
  • Dentium USA
  • Dentsply Sirona
  • Dyna Dental
  • Equinox
  • Euroteknika
  • Exactech
  • FGM
  • G. Surgiwear
  • GC Corporation
  • Geistlich
  • Genoss
  • Hans Biomed
  • Henry Schein
  • HOYA Technosurgical
  • IFGL Bio Ceramics Limited
  • Impladent LTD
  • Implant Direct
  • InBiomed
  • Inion
  • Intralock
  • JHS
  • Kasios
  • KaVo Kerr
  • Keramat
  • Keystone Dental
  • KOKEN
  • KYOCERA
  • Laboratorio Celina
  • LifeNet Health
  • Lutipold Pharmaceuticals
  • Lynch Biologics
  • Matcom
  • Medica-Integral
  • Medtronic
  • MegaGen
  • MIS Implants
  • MTF
  • Neobiotech
  • Neodent
  • Neoss
  • NIBEC
  • Nobel Biocare
  • Noraker
  • NovaBone
  • Odontit
  • Olympus Terumo Biomaterials
  • Oscotec
  • Osseocon
  • Ossix Dental
  • Osstem Implant
  • OST Development
  • Osteogenics
  • Osteohealth
  • OT Medical
  • Patterson
  • Pharmatrix
  • Regentix
  • Resorba
  • Rocky Mountain Tissue Bank
  • S.I.N.
  • Salvin
  • Shanghai Rebone Biomaterials
  • Shanxi OsteoRad
  • Sheng Chi Biotechnology
  • Silvestre Labs
  • Sistema INP
  • Snoasis Medical
  • Straumann
  • Sunmax Biotechnology
  • Sunstar
  • Tecnoss
  • Tianjin Sannie
  • Tirden
  • Tissue Banks
  • TreeOss
  • UNC
  • Unicare BioMedical
  • W. L. Gore
  • Zimmer Biomet

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology